BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 22374176)

  • 1. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
    Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
    Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
    Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
    Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
    Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
    Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
    Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
    He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
    Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guan Xin Dan Shen formulation protects
    Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model.
    Ni J; Li Y; Xu Y; Guo R
    Phytomedicine; 2021 Feb; 82():153406. PubMed ID: 33422954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
    Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
    J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes.
    Persson MF; Franzén S; Catrina SB; Dallner G; Hansell P; Brismar K; Palm F
    Diabetologia; 2012 May; 55(5):1535-43. PubMed ID: 22311417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
    Li C; Zhang J; Xue M; Li X; Han F; Liu X; Xu L; Lu Y; Cheng Y; Li T; Yu X; Sun B; Chen L
    Cardiovasc Diabetol; 2019 Feb; 18(1):15. PubMed ID: 30710997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tom70 protects against diabetic cardiomyopathy through its antioxidant and antiapoptotic properties.
    Wang P; Wang D; Yang Y; Hou J; Wan J; Ran F; Dai X; Zhou P; Yang Y
    Hypertens Res; 2020 Oct; 43(10):1047-1056. PubMed ID: 32724135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade.
    Sukumaran V; Tsuchimochi H; Tatsumi E; Shirai M; Pearson JT
    Biochem Pharmacol; 2017 Nov; 144():90-99. PubMed ID: 28789938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
    Ye Y; Birnbaum Y; Widen SG; Zhang Z; Zhu S; Bajaj M; Chen H
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):835-848. PubMed ID: 32767170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.